Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

555
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
555
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

5.1K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.1K
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

824
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
824
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

5.1K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.1K
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

47
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
47
Cancer Vaccines01:30

Cancer Vaccines

400
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
400

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Autophagy modulation in cancer.

Nature reviews. Drug discovery·2026
Same author

Multiomics immune profiling of a patient-relevant orthotopic lung cancer model using SEPARATE-Seq.

Nature communications·2026
Same author

NKG2A inhibition promotes NK cell-CD8<sup>+</sup> T cell interactions to improve anticancer immunity in ovarian carcinoma.

Nature communications·2026
Same author

Ovarian cancer metastasis to the human omentum disrupts organ homeostasis and induces fundamental tissue reprogramming.

Nature communications·2025
Same author

Context-dependent impact of type I interferon signaling in cancer.

Molecular cancer·2025
Same author

Partial mitochondrial involvement in the antiproliferative and immunostimulatory effects of PT-112.

Oncoimmunology·2025

相关实验视频

Updated: Jul 17, 2025

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
10:00

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

Published on: March 24, 2015

13.4K

一类干扰素和癌症

Peter Holicek1,2, Emma Guilbaud3, Vanessa Klapp4,5

  • 1Sotio Biotech, Prague, Czech Republic.

Immunological reviews
|September 5, 2023
PubMed
概括

I型干扰素 (IFN) 在癌症中具有双重作用. 强大的IFN反应与癌症作斗争,而弱的反应促进瘤生长和治疗耐药性,影响恶性转变和治疗结果.

关键词:
在CGAS中,CGAS是最重要的.一个刺1 一个刺1细胞死亡的阿波性细胞死亡.免疫性细胞死亡 免疫性细胞死亡干扰素刺激的基因是干扰素刺激的基因.模式识别受体的模式识别受体

更多相关视频

Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-&#945;
08:26

Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-α

Published on: June 14, 2018

12.1K
Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
08:19

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

6.0K

相关实验视频

Last Updated: Jul 17, 2025

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
10:00

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

Published on: March 24, 2015

13.4K
Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-&#945;
08:26

Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-α

Published on: June 14, 2018

12.1K
Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
08:19

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

6.0K

科学领域:

  • 免疫学 免疫学 免疫学
  • 在瘤学瘤学.
  • 分子生物学分子生物学

背景情况:

  • I型干扰素 (IFN) 是关键细胞因子,在癌症中具有复杂的作用.
  • 它们的信号影响恶性转变,瘤进展和治疗反应.
  • 取决于环境的影响范围从抗癌免疫到瘤促进.

研究的目的:

  • 审查I型IFN信号在癌症中的多方面的作用.
  • 阐明一类IFN的抗瘤和促瘤作用背后的机制.
  • 讨论对癌症治疗和治疗策略的影响.

主要方法:

  • 对I型IFN信号的基本方面进行文献综述.
  • 对恶性转变,瘤进展和治疗反应的上下文依赖影响的分析.
  • 综合了关于I型IFN的有益和有害作用的信息.

主要成果:

  • 强大的,急性I型IFN反应通过直接细胞毒性和免疫刺激表现出抗癌作用.
  • I型IFN信号传输对免疫治疗药物的有效性至关重要,例如ICD诱导剂和ICI.
  • 较弱,不解决的I型IFN反应促进瘤的进展,治疗耐药性,干性和免疫衰竭.

结论:

  • 第一种类型的IFN信号在瘤学中具有双刃剑.
  • 了解I型IFN的特定环境功能对于优化癌症治疗至关重要.
  • 向或调节I型IFN通路可能提供新的治疗策略.